Outsourcing-Pharma RSS

PRA Prepares to Go Public with Confidential SEC Filing

Zachary.Brennan@wrbm.com (Zachary Brennan) — Fri, 17 May 2013 20:15:03 +0200

US CRO PRA is proposing to go public again, more than six years since it was taken private, according to a confidential draft registration statement submitted to the US SEC.

UK ‘animal research’ labelling plan may have unintended consequences says Cyprotex

Gareth.MACDONALD@wrbm.com (Gareth MACDONALD) — Thu, 16 May 2013 14:31:53 +0200

Proposed UK “animal research” labelling laws may backfire if improvements in culture-based toxicology testing continue, according to in vitro CRO Cyprotex.

People on the Move: Outsourcing Jobs

Dan.Stanton@wrbm.com (Dan Stanton) — Thu, 16 May 2013 10:04:13 +0200

Outsourcing-Pharma.com presents its latest round-up of the movers and shakers in the pharma service industry, including news from Theorem and Symbiosis.

PPD Subsidiary Expands Biopharma Services with New China Lab

Zachary.Brennan@wrbm.com (Zachary Brennan) — Thu, 16 May 2013 00:00:27 +0200

BioDuro opened a new laboratory in Shanghai, China on Wednesday to offer a range of customized biopharma services for its Asia Pacific clients.

Quintiles Signs Exclusive Development Deal with Merck Days After $1B IPO

Zachary.Brennan@wrbm.com (Zachary Brennan) — Thu, 16 May 2013 23:10:40 +0200

Just days after raising more than $1B in its IPO, Quintiles announced Wednesday it signed a five-year clinical development agreement with Merck Serono.

West Adds Second Filling line in Prep for Future Crystal Zenith Boom

Dan.Stanton@wrbm.com (Dan Stanton) — Wed, 15 May 2013 13:11:16 +0200

Extra filling capacity is to be made available in preparation for West’s Crystal Zenith (CZ) system, though approval and increased sales are still at least 18 months away.

Yusen to Fly AstraZeneca's Drugs to Australia

Gareth.MACDONALD@wrbm.com (Gareth MACDONALD) — Wed, 15 May 2013 13:37:56 +0200

Yusen Logistics has launched a new air freight service to help UK drug major AstraZeneca ship its products to Australia in a new agreement announced today.

Dedicated Analytical Expansion Could Target New Clients, says Kemwell

Dan.Stanton@wrbm.com (Dan Stanton) — Wed, 15 May 2013 11:40:10 +0200

Kemwell says expansion of its Indian analytical services will service a major client but is part of an active growth strategy.

Clinical Cymru Can Compete on Costs says PRA

Gareth.MACDONALD@wrbm.com (Gareth MACDONALD) — Wed, 15 May 2013 12:41:40 +0200

PRA International says technology and IT innovation will help it compete with rivals that have moved their service centres to cheaper locations in the East to cut costs.

Wuxi Manufacturing Services Help Increase Quarterly Earnings

Zachary.Brennan@wrbm.com (Zachary Brennan) — Wed, 15 May 2013 00:11:59 +0200

Better than expected growth in Wuxi’s manufacturing services has driven the CRO to exceed its earlier guidance in the first quarter of 2013.

Aesica Accesses Atom-Efficient Amide Tech in Academic Accord

Gareth.MACDONALD@wrbm.com (Gareth MACDONALD) — Tue, 14 May 2013 12:14:12 +0200

Making amide bonds may be greener and cheaper in the future according to Aesica, which has partnered with UK scientists to commercialize a new synthesis technique.

Lack of Milestones Affect Q1 but Evotec Optimistic for Future

Dan.Stanton@wrbm.com (Dan Stanton) — Tue, 14 May 2013 11:56:10 +0200

Evotec says it is confident underlying growth, expansion of its clinical stage pipeline and upcoming milestone payments will counter Q1’s downcast results.

GSK and Kyowa Hakko Latest to Ink SE Asia Deals with DKSH

Dan.Stanton@wrbm.com (Dan Stanton) — Tue, 14 May 2013 13:03:44 +0200

In another contract with Big Pharma in Asia, DKSH has penned a contract sales deal with GlaxoSmithKline.

Former RPS CIO's Lawsuit Claims Wrongful Termination

Zachary.Brennan@wrbm.com (Zachary Brennan) — Tue, 14 May 2013 23:59:16 +0200

Research Pharmaceutical Services' (RPS) former chief information officer (CIO) claims he was unfairly dismissed after discovering the CRO was unlawfully storing potential employees' personal data.

Large Scale Manufacturing Drives AMRI Q1 Revenue Uptick

Zachary.Brennan@wrbm.com (Zachary Brennan) — Tue, 14 May 2013 17:57:38 +0200

Large scale manufacturing contract revenue in the first quarter of 2013 increased 14% over the same quarter in 2012 as AMRI (Albany Medical Research Inc.) saw an 11% increase in overall revenue.

SCM Named Commercial Supplier in Varisolve NDA

Gareth.MACDONALD@wrbm.com (Gareth MACDONALD) — Tue, 14 May 2013 12:23:52 +0200

Varicose veins could prove to be a big revenue stream for UK CMO SCM Pharma which has been named as commercial supplier for BTG’s candidate treatment, Varisolve.

Executives Raise Questions on Clinical Trial Sponsors’ Oversight of CROs

Zachary.Brennan@wrbm.com (Zachary Brennan) — Mon, 13 May 2013 22:37:27 +0200

Tension between clinical trial sponsors and CROs in terms of CRO oversight may not be relieved any time soon, but both sides seem intent on arriving at a middle ground where micromanagement stays low and the level of quality remains high.

McKesson Confident FY2014 Will See Revenue Growth

Dan.Stanton@wrbm.com (Dan Stanton) — Mon, 13 May 2013 11:56:33 +0200

Brand-to-generic conversions have been blamed for “somewhat softer than expected” financial results at McKesson, though significant FY2014 direct revenue growth has been predicted.

Recipharm to offer new metal-based delivery tech

Gareth.MACDONALD@wrbm.com (Gareth MACDONALD) — Mon, 13 May 2013 13:00:53 +0200

Melding metals to APIs could make drugs easier to deliver according to Sweden's Recipharm which partnered to add a new chemistry to its offering last week.

Local Indian Committees to Conduct Annual Inspections of Trial Sites

Zachary.Brennan@wrbm.com (Zachary Brennan) — Mon, 13 May 2013 21:28:18 +0200

Clinical trial sites in India will be inspected at least once a year under a new regulatory plan issued by the CDSCO.